These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3486267)

  • 1. Topical folinic acid therapy in methotrexate-induced oral ulceration.
    Barrett AP
    J Periodontol; 1986 May; 57(5):318-20. PubMed ID: 3486267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin "rescue".
    Capizzi RL; DeConti RC; Marsh JC; Bertino JR
    Cancer Res; 1970 Jun; 30(6):1782-8. PubMed ID: 4248129
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of topical administration of prostaglandin E2 on chemotherapy-associated oral mucosal lesions of the patients with hematological malignancies].
    Ueda E; Kitani T; Masaoka T; Horiuchi A; Yonezawa T
    Nihon Gan Chiryo Gakkai Shi; 1988 Mar; 23(3):752-8. PubMed ID: 3165420
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe oral ulceration in a patient taking low-dose methotrexate for rheumatoid arthritis.
    Pliskin ME; Lally ET; Quinn P
    Compend Contin Educ Dent (Lawrenceville); 1986 Jun; 7(6):430-3. PubMed ID: 3460734
    [No Abstract]   [Full Text] [Related]  

  • 5. Head and neck cancer. 3. Toxicity of 24-hour infusions of methotrexate (NSC-740) and protection by leucovorin (NSC-3590) in patients with epidermoid carcinomas.
    Lefkowitz E; Papac RJ; Bertino JR
    Cancer Chemother Rep; 1967 Sep; 51(5):305-11. PubMed ID: 4863189
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck.
    Mitchell MS; Wawro NW; DeConti RC; Kaplan SR; Papac R; Bertino JR
    Cancer Res; 1968 Jun; 28(6):1088-94. PubMed ID: 4298056
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of Adriamycin and mehtotrexate in carcinoma of the cervix. The development of a safe effective regimen.
    Guthrie D; Way S
    Obstet Gynecol; 1978 Sep; 52(3):349-54. PubMed ID: 309102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved therapeutic index of methotrexate with "leucovorin rescue".
    Levitt M; Mosher MB; DeConti RC; Farber LR; Skeel RT; Marsh JC; Mitchell MS; Papac RJ; Thomas ED; Bertino JR
    Cancer Res; 1973 Jul; 33(7):1729-34. PubMed ID: 4541737
    [No Abstract]   [Full Text] [Related]  

  • 9. Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis.
    Buckley LM; Vacek PM; Cooper SM
    J Rheumatol; 1990 Sep; 17(9):1158-61. PubMed ID: 2132565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose methotrexate with folinic acid rescue.
    Bender JF; Grove WR; Fortner CL
    Am J Hosp Pharm; 1977 Sep; 34(9):961-5. PubMed ID: 333910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predefinitive and postdefinitive chemotherapy for locally advanced squamous carcinoma of the head and neck.
    Kirkwood JM; Miller D; Weichselbaum R; Pitman SW
    Laryngoscope; 1979 Apr; 89(4):573-81. PubMed ID: 311882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experiences with enterally and parenterally applied leucovorin following therapy with high doses of methotrexate in malignant tumors (author's transl)].
    Vahrson H; Gorges K
    Med Klin; 1976 Oct; 71(41):1720-3. PubMed ID: 1086422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
    Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
    Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Initial results of cytostatic therapy of squamous cell carcinoma of the oral cavity using a combination of methotrexate and bleomycin].
    Bitter K
    Dtsch Zahn Mund Kieferheilkd Zentralbl Gesamte; 1973 Feb; 60(2):81-93. PubMed ID: 4122694
    [No Abstract]   [Full Text] [Related]  

  • 15. An effective combined therapy for advanced squamous cell carcinoma of the oral cavity: preoperative BVMM (bleomycin, vincristine, mitolactol plus methotrexate and leucovorin) chemotherapy followed by surgery.
    Olasz L; Szabó I; Horváth A
    Neoplasma; 1988; 35(5):591-7. PubMed ID: 3216933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methotrexate in the treatment of carcinoma of the oral mucosa].
    Paches AI; Liubaev VL; Shental' VV
    Stomatologiia (Mosk); 1973; 52(2):38-41. PubMed ID: 4513014
    [No Abstract]   [Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy in early-stage and locally advanced small bulk squamous cell carcinoma of the oral cavity and oropharynx.
    Tichler T; Ramon Y; Rath P; Hendler S; Brenner HJ
    Isr J Med Sci; 1988; 24(9-10):539-44. PubMed ID: 2462551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of oral methotrexate (mtx) in the treatment of tumours in the head and neck-region.
    Rietberg M
    Arch Chir Neerl; 1970; 22(2):107-16. PubMed ID: 4317753
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
    Edelman MJ; Meyers FJ; Houston J; Lauder I
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of oral ulceration.
    Macalister AD
    Drugs; 1973; 5(5):453-61. PubMed ID: 4353814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.